Vasopeptidase inhibition and angio-oedema
- 1 August 2000
- journal article
- editorial
- Published by Elsevier in The Lancet
- Vol. 356 (9230) , 608-609
- https://doi.org/10.1016/s0140-6736(00)02596-4
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Angiotensin II Receptor BlockersArchives of internal medicine (1960), 2000
- Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk PatientsNew England Journal of Medicine, 2000
- Angioedema due to angiotensin-converting enzyme inhibitorsImmunopharmacology, 1999
- Plasma bradykinin in angio-oedemaThe Lancet, 1998
- Angioedema Induced by the Angiotensin II Blocker LosartanNew England Journal of Medicine, 1995
- Failure to recognise the association of life-threatening angio-oedema and angiotensin-converting enzyme inhibitor therapyAustralian and New Zealand Journal of Medicine, 1995
- Plasma Kinins Increase after Angiotensin-Converting Enzyme Inhibition in Human SubjectsClinical Science, 1994
- Cough and Angioneurotic Edema Associated with Angiotensin-Converting Enzyme Inhibitor TherapyAnnals of Internal Medicine, 1992
- Hereditary Angioedema: the Clinical Syndrome and Its ManagementAnnals of Internal Medicine, 1976
- HEREDITARY ANGIO-NEUROTIC ŒDEMAThe Lancet Healthy Longevity, 1888